HBED: A Potential Oral Iron Chelator^a

This publication has 12 references indexed in Scilit:

• Rapid removal of excessive iron with daily, high-dose intravenous chelation therapy
  The Journal of Pediatrics, 1989
• Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one.
  BMJ, 1987
• 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE, AN ORALLY ACTIVE CHELATOR FOR TREATMENT OF IRON OVERLOAD
  The Lancet, 1987
• Effectiveness of oral iron chelators assayed in the rat
  American Journal of Hematology, 1987
• Esters and lactones of phenolic amino carboxylic acids. Prodrugs for iron chelation
  Journal of Medicinal Chemistry, 1986
• Iron chelation by pyridoxal isonicotinoyl hydrazone and analogues in hepatocytes in culture
  Biochemical Pharmacology, 1985
• Syntheses of iron(II) bis(pyridoxal isonicotinoylhydrazone)s and the in vivo iron-removal properties of some pyridoxal derivatives
  Journal of Medicinal Chemistry, 1983
• Effect of a specific iron chelating agent on animal models of inflammation.
  Annals of the Rheumatic Diseases, 1983
• A study of intracellular iron metabolism using pyridoxal isonicotinoyl hydrazone and other synthetic chelating agents
  Biochimica et Biophysica Acta (BBA) - General Subjects, 1979
• New Multidentate Ligands. VI. Chelating Tendencies of N,N′-Di(2-hydroxybenzyl)ethylenediamine-N,N′-diacetic Acid
  Journal of the American Chemical Society, 1967